Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy

CADASIL is a genetic small-vessel disease of the brain. It is caused by a harmful change (a “pathogenic variant”) in a gene called NOTCH3. This gene sits on chromosome 19 and gives the body instructions to build a protein that is mainly found on the surface of smooth muscle cells in small arteries. When this protein is altered, the small arteries get sick and stiff. Over time, blood does not flow as well as it should, tiny clots can form, and small deep strokes happen. White matter slowly gets damaged. People can have migraines with aura, short-lasting stroke-like attacks, real strokes, mood or thinking changes, walking and balance problems, and other symptoms.

CADASIL is a rare, inherited disease of the brain’s tiny arteries. A change (mutation) in a gene called NOTCH3 makes the muscle layer of those small arteries slowly get sick and stiff. Over time, blood flow to deep parts of the brain becomes patchy. This can cause migraine (often with aura), small strokes (lacunar strokes), thinking and memory problems, mood changes, and gradual disability. CADASIL is passed down in families in an autosomal dominant way, which means a parent with the condition has a 1-in-2 chance of passing it to each child. NCBI+1NINDS

---

What is happening in CADASIL?

Small arteries are like flexible tubes. Their walls have smooth muscle cells that tighten and relax to keep blood flow steady. The NOTCH3 protein sits on these cells and helps them “talk” to each other. In CADASIL, the NOTCH3 protein is misshaped because of a gene change. The misshaped protein builds up on the outside of the muscle cells in the artery wall. This build-up acts like trash that the cell cannot take out. The wall becomes thick and scarred. The space inside the artery becomes narrow. The artery cannot flex and regulate blood flow well. As a result, tiny areas of the brain get less blood and oxygen, either in short spells or in lasting ways. This harms the deep white matter and can cause small deep strokes. Over many years, this damage adds up and leads to problems with thinking, mood, and movement.

---

How common is it and who gets it?

CADASIL occurs worldwide. Men and women are both affected. Because it is autosomal dominant, a person with the condition has a 50% chance of passing the gene variant to each child. Some people also get the gene variant as a new change (de novo) even if their parents did not have the disease. Symptoms often start between the 20s and 50s, but timing varies a lot. Some people have mostly migraines for years. Others have early strokes. Some have late, slow changes in thinking and walking.

---

Types

Doctors do not divide CADASIL into strict official “types” like Type 1, Type 2, etc. But in real life, people can show different patterns. These patterns help doctors think about the disease. You can think of them as clinical subtypes:

1. Migraine-dominant pattern
   The main early problem is migraine, often with aura (visual sparkles, flashing zig-zags, blind spots, or numbness that spreads), sometimes starting in the 20s or 30s. Strokes may not appear until later.

2. TIA/Stroke-dominant pattern
   People have brief stroke-like spells (TIAs) or definite small deep strokes early, often in the 30s to 50s. Weakness, numbness, slurred speech, or face droop can happen during attacks.

3. Cognitive-dominant pattern
   The main issue is a slow change in thinking, planning, attention, and memory, often from the 40s onward. Day-to-day tasks and work get harder over time.

4. Mood/psychiatric-dominant pattern
   Depression, apathy, anxiety, or irritability stand out. These are brain-based changes and part of the disease, not a personal weakness.

5. Gait and balance-dominant pattern
   Problems with walking, balance, and falls are early or prominent. The person may shuffle, feel unsteady, or walk more slowly.

6. Seizure-associated pattern
   A smaller group has seizures at some point. Seizures can be the first sign or appear after strokes.

7. Hemorrhagic/microbleed-prone pattern
   Some people have many microbleeds on MRI. Rarely, a larger brain bleed happens. Headaches and thinking problems can be worse in this group.

8. Late-onset pattern
   Symptoms start later than usual, for example in the 60s, sometimes after a lifetime of migraines or no obvious early signs.

9. Childhood/teen-onset pattern (rare)
   Rarely, headaches, seizures, or MRI white-matter changes appear in childhood.

10. Very mild or “silent” pattern
    Some people carry the gene change but have few symptoms for many years. MRI may show changes before the person notices problems.

These patterns can overlap and can change over time in the same person.

---

Causes

Important note: The true cause of CADASIL is a pathogenic variant in the NOTCH3 gene. The other items below do not cause CADASIL by themselves. They are contributors that can raise stroke risk, worsen small-vessel damage, make symptoms show sooner, or mimic the disease. We list them so you can understand what can make things better or worse.

1. NOTCH3 gene variant (cysteine-altering missense change)
   This is the root cause. It changes the shape of the NOTCH3 protein on artery muscle cells. The protein collects in the vessel wall and harms it.

2. Having an affected parent (autosomal dominant inheritance)
   Each child has a 50% chance to inherit the variant if a parent has it.

3. New (de novo) gene change
   The variant can arise new in the egg or sperm or very early after conception, even if neither parent is affected.

4. High blood pressure (hypertension)
   High pressure stresses small arteries and speeds up damage. Good control helps protect the brain.

5. Cigarette smoking or other nicotine exposure
   Smoking narrows arteries and makes blood more likely to clot. It worsens small-vessel disease and raises stroke risk.

6. Diabetes
   High sugar damages small blood vessels and worsens white-matter injury over time.

7. High LDL cholesterol and high triglycerides
   Abnormal lipids harm blood vessels. Control reduces stroke risk.

8. Obesity and physical inactivity
   These increase risk for high blood pressure, diabetes, and poor blood flow.

9. Obstructive sleep apnea
   Repeated drops in oxygen stress the brain’s small vessels and can worsen thinking and mood.

10. High homocysteine (from B12/folate deficiency or genetics)
    Homocysteine can injure endothelium (the lining of vessels). Treating vitamin deficiency can lower levels.

11. Frequent migraine with aura
    In CADASIL, migraine is part of the disease. Frequent attacks may link with a higher risk of small deep strokes.

12. Dehydration and severe illness
    Low blood volume or infection can reduce brain perfusion and unmask symptoms.

13. Estrogen-containing birth control or hormone therapy
    These can increase clot and stroke risk in some people; decisions should be individualized.

14. Cocaine or stimulant drug use
    These can spasm blood vessels and cause strokes.

15. Uncontrolled atrial fibrillation or heart disease
    Not a CADASIL cause, but raises stroke risk from clots; managing heart rhythm matters.

16. Chronic kidney disease
    Vascular injury from kidney disease can add to small-vessel brain damage.

17. Head trauma
    Concussion or head injury may worsen symptoms or precipitate seizures.

18. Severe anemia or polycythemia
    Abnormal blood oxygen carrying or thickness can reduce oxygen delivery or impair flow.

19. Autoimmune vasculitis (as a mimic)
    Not a cause of CADASIL, but can look similar. It matters because treatments differ, so doctors must rule it out.

20. Other genetic modifiers
    Variants in other genes may modify severity, age of onset, or MRI pattern. These do not cause CADASIL alone but may shape how it looks in a family.

---

Common symptoms

Symptoms vary. They can be mild at first and grow slowly. They can also come in steps after small strokes. Not everyone has all symptoms.

1. Migraine with aura
   Throbbing headache with visual zig-zags, flashing lights, or blind spots. Numbness or speech problems can occur before the pain. This often starts early.

2. Transient ischemic attacks (TIAs)
   Short-lasting stroke-like spells that get better within minutes to hours. Face droop, weakness, numbness, or slurred speech can occur.

3. Ischemic strokes
   Lasting loss of function from blocked small arteries in deep brain areas. This can cause weakness, clumsy hand, numbness, or speech changes.

4. Cognitive changes
   Trouble with planning, multitasking, attention, and processing speed. Memory may be mostly for recent tasks and lists. Thinking can slow over years.

5. Apathy and depression
   Loss of drive, low mood, or less interest in activities. This is brain-based and common in small-vessel disease.

6. Anxiety and irritability
   Worry, restlessness, or short temper can occur, often with stress or when symptoms flare.

7. Balance problems and unsteady gait
   Walking becomes slower and less steady. Falls may happen more often, especially in the dark or on uneven ground.

8. Fine motor clumsiness
   Buttoning a shirt, writing, or using keys can feel awkward on one side or overall.

9. Speech problems
   Slurred speech or trouble finding words, especially during or after TIAs or strokes.

10. Numbness or tingling
    Patchy sensory changes on the face, arm, or leg, often on one side.

11. Urinary urgency or incontinence
    White-matter damage can disrupt bladder control paths over time.

12. Fatigue
    A heavy, tired feeling that is out of proportion to activity. Sleep quality and mood can add to this.

13. Seizures
    Less common but possible. They may involve staring spells, confusion, or shaking.

14. Vision symptoms
    Aura visual effects (sparkles, zig-zags) or blurred vision during attacks; rarely, lasting visual field cuts after strokes.

15. Swallowing difficulty (dysphagia)
    After deeper strokes, some people cough with liquids or feel food “sticking.”

---

Diagnostic tests

Doctors combine your story, family history, exam, and tests to make the diagnosis. The gold standards are genetic testing and, when needed, skin biopsy showing changes typical of CADASIL. MRI patterns also help a lot. Below are 20 tests in five groups.

A) Physical Exam

1. General neurological exam
   The doctor checks alertness, attention, language, memory, and mood. They look for weakness, numbness, reflex changes, and coordination problems.

2. Cranial nerve exam
   The doctor checks eye movements, visual fields, facial strength and feeling, hearing, palate movement, and tongue strength. This looks for areas affected by small deep strokes.

3. Motor and sensory exam
   Strength, muscle tone, and rapid movements are tested. Light touch, pin, vibration, and position sense are checked to map deficits.

4. Gait and balance exam
   You are observed walking normally, on heels and toes, and in tandem (heel-to-toe). The Romberg test (standing with eyes closed) looks for sway and balance issues.

B) Manual Tests (bedside scales and paper-and-pencil)

5. MoCA (Montreal Cognitive Assessment)
   A 10–15 minute screen for attention, memory, language, and executive skills. It is sensitive to small-vessel cognitive changes.

6. Trail Making Test (Parts A and B)
   Paper tests of processing speed and task-switching. People with white-matter disease often take longer, especially on Part B.

7. Timed Up and Go (TUG)
   A simple mobility test: stand up, walk 3 meters, turn, walk back, sit. Times over 12–15 seconds suggest gait and balance risk.

8. 9-Hole Peg Test
   A fine motor speed test for each hand. It can pick up subtle clumsiness after small deep strokes.

C) Lab and Pathological Tests

9. Genetic testing for NOTCH3
   This is the definitive test. It looks for pathogenic variants in the NOTCH3 gene. A positive result with the right symptoms confirms CADASIL.

10. Skin biopsy with electron microscopy
    A small skin sample is taken, usually from the forearm. Under electron microscopy, doctors look for granular osmiophilic material (GOM) in the walls of tiny arteries. GOM strongly supports the diagnosis.

11. Skin biopsy immunohistochemistry for NOTCH3
    Special stains show NOTCH3 protein build-up in small vessel walls. This supports the diagnosis and can be easier to perform than electron microscopy in some centers.

12. Rule-out labs
    Blood tests check for other causes of small-vessel disease or stroke: complete blood count, metabolic panel, kidney function, thyroid, B12/folate, homocysteine, fasting glucose or HbA1c, and lipid profile. These do not diagnose CADASIL but help guide care.

13. Autoimmune/infectious screen (when needed)
    Tests like ANA, ANCA, syphilis, or HIV are done when the story does not fit or when another disease is suspected. These help avoid misdiagnosis.

D) Electrodiagnostic Tests

14. Electroencephalogram (EEG)
    If seizures or spells of confusion occur, EEG records brain waves to look for epileptic activity or slowings linked to prior strokes.

15. Evoked potentials (VEP/SSEP, as needed)
    These measure the brain’s response to visual or sensory signals. They can detect slowed conduction in white-matter pathways.

16. Polysomnography (sleep study)
    If sleep apnea is suspected, an overnight study checks breathing pauses that can worsen small-vessel injury and daytime fatigue.

E) Imaging Tests

17. Brain MRI with T2/FLAIR
    This is the key imaging test. It shows bright white-matter changes, often in the front of the temporal lobes and the external capsule, which are very suggestive of CADASIL. It also shows small deep strokes (lacunes).

18. Diffusion-weighted MRI (DWI)
    This sequence spots fresh strokes within minutes to hours. It helps when someone has new symptoms.

19. Susceptibility-weighted imaging (SWI) or T2*
    This looks for microbleeds—tiny old blood spots that can occur in CADASIL and affect treatment decisions.

20. MRA/CTA or carotid ultrasound (as context tests)
    These check the larger arteries for blockages. In CADASIL they are often normal, which helps point to small-vessel rather than large-vessel disease.

Non-pharmacological treatments

These are things you can do or receive that do not rely on prescription drugs to change the course of daily living. I explain the purpose and simple mechanism behind each.

1. Blood-pressure control routines (daily monitoring + habits).
   Purpose: keep blood pressure consistently in a safe range, which lowers overall stroke risk.
   How it helps: high pressure damages small vessels; steady, normal pressure protects them. (Medication may be needed, but daily habits and home checks are non-drug.) Target in stroke survivors commonly used by guidelines is <130/80 mm Hg, customized by your clinician. AAFP

2. Mediterranean-style eating pattern.
   Purpose: reduce stroke and heart risk.
   How it helps: emphasizes vegetables, fruit, whole grains, legumes, nuts, fish, and olive oil; limits salt and processed foods—this improves lipids, blood pressure, and vessel health. AHA/ASA endorses this approach after stroke. AAFP

3. Salt reduction.
   Purpose: help blood pressure and reduce fluid strain on vessels.
   How it helps: less sodium → lower pressure in many people. (A reasonable goal discussed by AHA/ASA is ~2.5 g sodium/day, individualized.) AAFP

4. Regular physical activity (within your safe limits).
   Purpose: cut risk of another stroke, improve thinking speed, mood, and balance.
   How it helps: exercise improves blood flow, lowers inflammation, and conditions small vessels. Guidelines support brief regular sessions each week after stroke. AAFP

5. Quit smoking (and avoid second-hand smoke).
   Purpose: strongly reduce small-vessel injury and stroke risk.
   How it helps: smoking injures vessel lining and thickens small arteries — the last thing CADASIL-affected vessels need. AAFP

6. Sleep optimization & screening for sleep apnea.
   Purpose: prevent night-time oxygen dips that strain brain vessels.
   How it helps: treating sleep apnea (e.g., CPAP) and getting regular sleep stabilizes blood pressure and brain oxygen.

7. Migraine trigger management + headache diary.
   Purpose: reduce how often and how intense attacks are.
   How it helps: tracking foods, stress, hormones, lighting, or sleep loss helps identify and avoid personal triggers. (In CADASIL, triptans can be used but usually not as first choice—see medications section.) VASCERN

8. Stress management (CBT, mindfulness, relaxation training).
   Purpose: lower adrenaline-driven pressure spikes and pain amplification.
   How it helps: calmer autonomic tone → steadier blood pressure, better headache control.

9. Cognitive rehabilitation.
   Purpose: support memory, attention, and planning when thinking slows.
   How it helps: therapists teach strategies (lists, routines, spaced practice) and brain exercises to work around white-matter “traffic jams.”

10. Speech-language therapy (for language or swallowing).
    Purpose: improve word-finding, speech clarity, or safe swallowing after small strokes.
    How it helps: targeted exercises build alternative neural pathways and safer habits.

11. Physical therapy (gait, balance, strength).
    Purpose: preserve walking safety and reduce falls.
    How it helps: practice and muscle strengthening compensate for small-stroke weaknesses.

12. Occupational therapy (daily-living skills).
    Purpose: keep independence in dressing, bathing, cooking, and work tasks.
    How it helps: task-specific training and home/workplace adaptations reduce fatigue and risk.

13. Vision & vestibular therapy (if visual aura or dizziness is troublesome).
    Purpose: reduce disequilibrium and visual discomfort.
    How it helps: training stabilizes eye-head coordination and decreases visually triggered symptoms.

14. Home fall-prevention modifications.
    Purpose: prevent injuries that can compound disability.
    How it helps: better lighting, grab bars, remove tripping hazards, proper footwear.

15. Alcohol moderation or avoidance.
    Purpose: lower stroke risk and reduce migraine triggers.
    How it helps: heavy use raises blood pressure and can trigger headaches; guidelines recommend no more than 1 drink/day for women, 2 for men—many with CADASIL do better with less. AAFP

16. Vaccination & infection-prevention habits.
    Purpose: avoid infections that spike inflammation and blood pressure.
    How it helps: fewer febrile illnesses → fewer physiologic stressors for fragile vessels.

17. Heat/illness hydration plan.
    Purpose: avoid dehydration-related pressure swings and headache.
    How it helps: stable hydration supports steady cerebral perfusion.

18. Pregnancy planning with neurology & obstetrics.
    Purpose: get personalized risk counseling.
    How it helps: pregnancy itself doesn’t seem to raise stroke risk in CADASIL overall, but migraines can flare; unnecessary antithrombotics in pregnancy aren’t advised unless another clear reason exists. VASCERN

19. Anesthesia planning.
    Purpose: avoid large blood-pressure drops during procedures.
    How it helps: careful anesthetic management protects brain perfusion in CADASIL. VASCERN

20. Genetic counseling for the family.
    Purpose: explain inheritance, testing options, and life planning.
    How it helps: CADASIL is autosomal dominant; counseling helps relatives understand 50% transmission risk and testing decisions. NCBI

---

Drug treatments

Key principles first:
• There’s no proven disease-modifying drug for CADASIL yet.
• Antiplatelets may be used after a clinical ischemic event or when small deep infarcts are present, but benefit in CADASIL specifically is unproven; start only after individualized discussion.
• Anticoagulants (e.g., for atrial fibrillation) or statins (for standard dyslipidemia indications) may be appropriate for other reasons, not for CADASIL itself.
• Triptans for migraine are not formally contraindicated but are recommended as second/third choice; use non-vasoconstrictors first when possible. VASCERN

1. Aspirin (antiplatelet), 75–100 mg once daily.
   Purpose: lower risk of another ischemic event after TIA/stroke.
   Mechanism: reduces platelet clumping.
   Timing: daily, taken long-term if there’s a qualifying ischemic indication.
   Common side effects: stomach upset, bleeding risk.
   CADASIL note: use only after a clinical ischemic event or when infarcts are present on imaging, and after discussing risks and benefits. VASCERN

2. Clopidogrel (antiplatelet), 75 mg once daily.
   Purpose/Mechanism: alternative to aspirin; P2Y12 platelet receptor blocker.
   Side effects: bruising, bleeding, rare rash.
   CADASIL note: same indication caution as aspirin. VASCERN

3. Perindopril (ACE inhibitor), typical 4–8 mg daily (range individualized).
   Purpose: control blood pressure (a major stroke risk factor in everyone).
   Mechanism: relaxes blood vessels and lowers pressure.
   Side effects: cough, dizziness, high potassium.
   CADASIL note: BP control is central to stroke prevention in general stroke guidelines. AAFP

4. Amlodipine (calcium-channel blocker), 5–10 mg daily.
   Purpose/Mechanism: vasodilator for blood-pressure control.
   Side effects: ankle swelling, flushing, headache.
   CADASIL note: used to reach BP goals set for the individual. AAFP

5. Hydrochlorothiazide (thiazide diuretic), 12.5–25 mg daily.
   Purpose: additional blood-pressure lowering.
   Mechanism: helps the body shed salt and water.
   Side effects: low potassium, frequent urination, gout flares. AAFP

6. Atorvastatin, 10–80 mg nightly (only if you meet standard lipid indications).
   Purpose: treat dyslipidemia/ASCVD risk; not for CADASIL specifically.
   Mechanism: blocks cholesterol synthesis.
   Side effects: muscle aches, rare liver enzyme rise.
   CADASIL note: not recommended solely to prevent CADASIL-related stroke; use only for routine cholesterol indications. VASCERN

7. Acetaminophen or NSAIDs for acute migraine (first-line).
   Purpose: relieve headache pain.
   Mechanism: pain modulation; NSAIDs reduce inflammation.
   Side effects: acetaminophen—liver risk at high doses; NSAIDs—stomach and bleeding risk.
   CADASIL note: start with these before vasoconstrictors; weigh NSAID bleeding risk if you’re also on antiplatelets. VASCERN

8. Triptans (e.g., sumatriptan 50–100 mg at onset; may repeat once).
   Purpose: abort moderate–severe migraine that fails simple analgesics.
   Mechanism: serotonin receptor agonists that constrict migraine-dilated cranial vessels and quiet pain pathways.
   Side effects: chest/neck tightness, tingling, flushing.
   CADASIL note: Not contraindicated but advised as second/third-line because of vasoconstriction; use with neurologist oversight. VASCERN

9. Topiramate (migraine prevention), start 25 mg nightly; titrate to 50 mg twice daily as tolerated.
   Purpose: reduce migraine frequency.
   Mechanism: calms over-excitable brain circuits.
   Side effects: tingling, word-finding issues, appetite/weight change, kidney stone risk.
   CADASIL note: preventive choices are individualized; topiramate is commonly used for migraine prevention.

10. Propranolol (migraine prevention), 40–80 mg/day divided.
    Purpose: reduce frequency and intensity of migraine.
    Mechanism: beta-blocker dampening of adrenergic surges.
    Side effects: fatigue, slow pulse, sleep disturbance.
    CADASIL note: choose preventive based on comorbidities (e.g., avoid in asthma). PubMedAmerican Heart Association Journals

---

Dietary molecular supplements

Important: No supplement has been proven to stop or reverse CADASIL. Some have evidence for migraine prevention or general cardiometabolic health. Always discuss interactions (especially if you use antiplatelets or anticoagulants).

1. Magnesium (oxide or citrate) 400–600 mg daily.
   Function: supports nerve and vessel stability; low magnesium is linked to migraine.
   Mechanism: blocks NMDA excitability; stabilizes smooth muscle. Evidence supports use in migraine prevention. American Headache SocietyAmerican Migraine Foundation

2. Riboflavin (vitamin B2) 400 mg daily.
   Function: improves mitochondrial energy supply in brain cells.
   Mechanism: boosts ATP generation; guideline-supported for migraine prevention. pmc.ncbi.nlm.nih.gov

3. Coenzyme Q10 (100 mg three times daily).
   Function: antioxidant/mitochondrial cofactor that may reduce migraine frequency.
   Mechanism: improves cellular energy and reduces oxidative stress. ScienceDirect

4. Omega-3 fatty acids (EPA+DHA 1–2 g/day from fish oil) or diet-based fish intake.
   Function: anti-inflammatory and cardioprotective.
   Mechanism: alters eicosanoid signaling and membrane composition; general CV benefit is diet-supported. (High-dose prescription omega-3 for stroke prevention is debated.) AAFP

5. Vitamin D (dose based on blood level; commonly 1000–2000 IU/day).
   Function: supports immune and vascular health; correct deficiency.
   Mechanism: modulates inflammation and endothelial function.

6. Melatonin 2–5 mg nightly.
   Function: steadier sleep; may reduce migraine frequency in some.
   Mechanism: circadian stabilization, antioxidant effects.

7. Alpha-lipoic acid 300–600 mg/day.
   Function: antioxidant; studied in migraine/metabolic health.
   Mechanism: reduces oxidative stress in neurons and vessels.

8. Vitamin B12 (dose per deficiency status).
   Function: supports myelin and lowers homocysteine with folate.
   Mechanism: methylation pathways; corrects deficiency that can worsen neurologic function.

9. Folate (0.4–1 mg/day; higher if prescribed).
   Function: lowers homocysteine when low; supports vascular health.
   Mechanism: one-carbon metabolism.

10. Magnesium glycinate at night (alternative form if oxide causes GI upset).
    Function/Mechanism: same migraine-prevention rationale with better GI tolerance.

Notes: Feverfew and butterbur are sometimes discussed for migraine; butterbur can damage the liver unless you use PA-free, quality-assured products—most clinicians avoid it. Always check interactions if you are on aspirin or clopidogrel.

---

Regenerative / stem-cell / immune-targeting” strategies

These are not approved treatments for CADASIL. They’re research ideas that target the NOTCH3 problem more directly. I list them to keep you aware of where science is going.

1. Antisense-oligonucleotide (ASO) “exon-skipping” for NOTCH3 (preclinical).
   What it is: short genetic “patches” that make cells skip a faulty exon in NOTCH3 mRNA so the resulting protein avoids the harmful cysteine mismatch.
   Mechanism: reduces NOTCH3 aggregation; may soften vessel pathology (so far in cells/early work). No clinical dosing exists yet. pmc.ncbi.nlm.nih.gov+1

2. Monoclonal antibodies against the NOTCH3 extracellular domain (preclinical).
   What it is: lab-made antibodies that bind the abnormal NOTCH3 outside the cell.
   Mechanism: in animal models, reduces NOTCH3 deposits and vascular changes—a disease-modifying concept in mice, not in people yet. PubMedEMBOPRESS

3. Gene-editing (CRISPR-based) concepts.
   What it is: tools that could correct a specific NOTCH3 mutation at DNA level.
   Mechanism: proof-of-concept exists in cell systems; human therapy is not available. pmc.ncbi.nlm.nih.gov

4. ASO “boosters,” e.g., epigenetic co-treatments to improve exon skipping (preclinical).
   Mechanism: may enhance ASO effect; still bench science. ScienceDirect

5. Endothelial or vascular-smooth-muscle cell–based repair (conceptual).
   Mechanism: future cell therapies might replace damaged mural cells; this remains theoretical in CADASIL and carries clot/bleed risks that would need careful trials.

6. CGRP-pathway biologics for migraine (approved for migraine in general, not disease-modifying for CADASIL).
   Mechanism: reduce migraine frequency without vasoconstriction; case reports in CADASIL show benefit, but some experts caution about theoretical ischemia concerns—decide with a specialist. MDPIpmc.ncbi.nlm.nih.gov

---

Procedures/surgeries

There is no surgery that treats CADASIL itself. A few supportive procedures may be used for complications, and some procedures are usually avoided unless there’s a separate reason.

1. Feeding tube (PEG) placement if severe swallowing problems lead to unsafe aspiration or malnutrition.
   Why: protects lungs and nutrition when dysphagia is dangerous.

2. Tracheostomy in rare, severe respiratory situations.
   Why: long-term airway protection if neurologic disability is advanced.

3. Decompressive craniectomy for large brain swelling after a big stroke (uncommon pattern in CADASIL).
   Why: lifesaving in malignant edema; used per standard stroke criteria, not CADASIL-specific.

4. Cardiac procedures (e.g., pacemaker/loop recorder) only if a separate heart rhythm problem exists.
   Why: not for CADASIL itself—done when arrhythmias are proven.

5. Catheter angiography is generally not recommended just to “look” at vessels in CADASIL due to risk of worsening migraine/encephalopathy; noninvasive imaging is preferred. VASCERN

(Separately, carotid endarterectomy/stenting are for large-artery neck disease and usually don’t apply in CADASIL, which is a small-vessel disorder.)

---

Prevention

1. Keep blood pressure in a safe, steady range (often <130/80 after stroke, individualized). AAFP

2. Don’t smoke; avoid second-hand smoke. AAFP

3. Follow a Mediterranean-style diet and limit salt. AAFP

4. Move regularly each week; build up gradually. AAFP

5. Limit alcohol (many do best with none or very little). AAFP

6. Track and tame migraines (sleep routine, trigger diary, stress care). VASCERN

7. Plan anesthesia and major procedures to avoid big blood-pressure swings. VASCERN

8. Get sleep apnea evaluated if you snore or feel unrefreshed.

9. Vaccinate and treat infections promptly to reduce physiologic stress.

10. Genetic counseling for family planning and cascade testing. NCBI

---

When to see a doctor urgently

Call emergency services right away if you notice any stroke-like signs (sudden weakness, numbness, face droop, trouble speaking, sudden vision loss, severe imbalance), a brand-new worst headache, seizure, confusion, or an aura that is very different, much longer, or followed by new neurologic symptoms. (In acute CADASIL lacunar stroke, some experts advise avoiding IV thrombolysis because of bleeding risk—emergency teams weigh risks/benefits case-by-case.) VASCERN

Make a routine appointment if you have: slowly worsening memory or planning problems; frequent or changing migraines; depression, apathy, or anxiety; concerns about pregnancy, anesthesia, or a new medication; family members asking about testing. NCBI

---

What to eat more of — and what to avoid

1. More: vegetables, fruits, legumes, whole grains, nuts, seeds, olive oil; Why: heart- and vessel-healthy base. AAFP

2. More: fish (esp. oily fish) 1–2×/week.

3. More: water; steady hydration.

4. More: potassium-rich foods (bananas, leafy greens, beans) if your kidneys and meds allow.

5. Limit: salt — learn label reading and cooking swaps. AAFP

6. Limit: processed meats, deep-fried foods, trans fats.

7. Limit: excess alcohol; many prefer 0. AAFP

8. Be cautious: migraine trigger foods (aged cheeses, red wine, MSG, very processed snacks) if you notice a personal link.

9. Steady caffeine (either small regular amount or none); big swings can trigger headaches.

10. Supplements only if useful and safe alongside your medicines (see list above; discuss with your clinician).

---

FAQs

1) Is CADASIL the same as “small-vessel disease”?
CADASIL is one cause of small-vessel disease and is genetic; most small-vessel disease in the general population is due to age, hypertension, or diabetes. JCN

2) How is CADASIL diagnosed?
Mainly by NOTCH3 genetic testing. MRI patterns help, and sometimes skin biopsy is used. NCBI

3) Can CADASIL skip a generation?
It’s autosomal dominant, so each child has a 50% chance if a parent is affected; it usually doesn’t “skip,” but symptoms vary widely. NCBI

4) What ages do symptoms start?
Anywhere from young adulthood to later midlife; migraines can come first, then small strokes, then cognitive changes over decades. NCBI

5) Is there a cure?
No. Care focuses on stroke-risk reduction and symptom control. Experimental genetic/antibody approaches are being studied. pmc.ncbi.nlm.nih.govPubMed

6) Should I take aspirin to “prevent” my first stroke?
Not automatically. In CADASIL, experts say use antiplatelets only after an ischemic event or when small infarcts are seen—talk to your neurologist. VASCERN

7) Are anticoagulants (like apixaban) safe in CADASIL?
They’re not used to prevent CADASIL-related lacunar strokes and may raise bleeding risk—but they can be used if there’s a separate strong reason (like atrial fibrillation), with careful risk–benefit review. VASCERN

8) Should I be on a statin?
Only if you meet regular cholesterol indications; statins are not recommended just because you have CADASIL. VASCERN

9) Are triptans banned?
No. They’re not contraindicated, but because they constrict vessels, experts advise second/third-line status after simple analgesics. VASCERN

10) What about CGRP blockers for migraine?
Some CADASIL case reports show benefit, but a few experts worry about theoretical ischemia risk. Decide with a headache specialist familiar with CADASIL. MDPIpmc.ncbi.nlm.nih.gov

11) Does pregnancy worsen CADASIL?
Overall, pregnancy doesn’t appear to raise stroke risk in CADASIL, but migraines can flare around pregnancy or postpartum. Preventive heparin/aspirin in pregnancy isn’t routinely advised unless there’s another reason. VASCERN

12) Can I donate organs?
Yes—organ donation is considered possible in CADASIL; there’s no significant disease in other organs. VASCERN

13) Will cognitive enhancers help?
Donepezil did not improve the main global cognitive score in a trial, though some executive tests improved a little; clinical impact is unclear. PubMed

14) Are there “types” of CADASIL?
Not formal “types,” but many different NOTCH3 mutations exist with variable severity; related disorders (like CARASIL, which is recessive) are different conditions. JCNorpha.net

15) What should my care team look like?
A neurologist (preferably with stroke and/or genetics interest), genetic counselor, and rehab specialists (PT/OT/SLP), plus primary care to coordinate risk-factor control and preventive health. NCBI

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 15, 2025.